MPX International (FRA:2J6) EBITDA Margin % : -153.76% (As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is MPX International EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. MPX International's EBITDA for the three months ended in Mar. 2022 was €-2.23 Mil. MPX International's Revenue for the three months ended in Mar. 2022 was €1.45 Mil. Therefore, MPX International's EBITDA margin for the quarter that ended in Mar. 2022 was -153.76%.

MPX International EBITDA Margin % Historical Data

The historical data trend for MPX International's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MPX International EBITDA Margin % Chart

MPX International Annual Data

Trend

Sep18

Sep19

Sep20

Sep21

EBITDA Margin %

-2,361.90

-375.37

-1,137.44

-222.02

MPX International Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
EBITDA Margin %	Get a 7-Day Free Trial												-307.74	8.12	-678.84	-79.20	-153.76

Competitive Comparison of MPX International's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, MPX International's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MPX International's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MPX International's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where MPX International's EBITDA Margin % falls into.

MPX International EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

MPX International's EBITDA Margin % for the fiscal year that ended in Sep. 2021 is calculated as

EBITDA Margin %	=	EBITDA (A: Sep. 2021 )	/	Revenue (A: Sep. 2021 )
	=	-10.739	/	4.837
	=	-222.02 %

MPX International's EBITDA Margin % for the quarter that ended in Mar. 2022 is calculated as

EBITDA Margin %	=	EBITDA (Q: Mar. 2022 )	/	Revenue (Q: Mar. 2022 )
	=	-2.228	/	1.449
	=	-153.76 %

MPX International (FRA:2J6) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

MPX International EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of MPX International's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

MPX International (FRA:2J6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MPX International Corp (FRA:2J6) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5255 Yonge Street, Suite 701, Toronto, ON, CAN, M2N 6P4

Website

https://www.mpxinternationalcorp.com

MPX International Corp is a diversified cannabis company focused on developing and operating assets across the global medical and adult use and engaged in cultivating, manufacturing and marketing products that include cannabinoids as their primary active ingredient. The firm is organized into three segments: Canada, Europe/Africa, and Asia-Pacific. The Canada operating segment's principal business activities consist of production and sale of cannabis, video learning and engagement, patient counselling and referral services. The Europe/Africa operating segment's consist of the production and sale of cannabis and hemp-related products. The Asia-Pacific consist of the production and sale of cannabis. The majority of the revenue is generated in Canada.

MPX International (FRA:2J6) Headlines

No Headlines